Here's why Vinay Rajani is bullish on KIMS, Pfizer; bearish on Nifty

On the broader market outlook, the technical analyst from HDFC Securities says that the indicators and oscillators have turned bearish on the short term charts for the Nifty 50.

Markets, stocks, buy, sell, trading, shares, stock market
Vinay Rajani Mumbai
2 min read Last Updated : Oct 12 2022 | 8:22 AM IST
Nifty View

The Nifty fell for the third consecutive session, to close below 17,000 mark. The Nifty has reached near its 200-day EMA, placed at 16,900 odd level. Indicators and oscillators have turned bearish on the short term charts. 

Below 16,900, the Nifty could drag towards next supports of 16,750 and 16,600. Resistance for Nifty has shifted down to 17,300 level. 

BUY
Krishna Institute of Medical Sciences (KIMS)
Last close: Rs 1,466

Also Read

Targets: Rs 1670; Rs 1,770
Stop Loss: Rs 1,350

The stock price has been finding support at its 30-day EMA and has bounced back from there after giving a "Flag" pattern breakout on the daily chart. The volume during price rise has been high and volume during price fall remains very low.

The stock is trading above its 20-, 50-, 100- and 200-DMAs, indicating uptrend on all time frames. The DMI Indicator has been showing strength in the current uptrend.

BUY
Pfizer
Last close: Rs 4432
Targets: Rs 4,725; Rs 4,900
Stop Loss: Rs 4,300

The stock price has been finding support at its 50-day EMA and the stock has also reached at fresh all-time highs on a closing basis.

The primary trend of the stock has been bullish with higher top and higher bottom formation. Further, pharma sector has started outperforming after long time. The dtock is placed above all important moving averages, which indicates bullish trend on all time frames. 

(Vinay Rajani, Senior Technical and Derivative Research Analyst at HDFC securities. Views expressed are personal).

 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Market technicalsMarket trendsNifty OutlookMarket Outlookstocks technical analysistechnical chartsstock market tradingStocks to buyTrading strategies

Next Story